Telomir Pharmaceuticals (TELO) Debt Ratio (2023 - 2026)
Telomir Pharmaceuticals (TELO) posted Debt Ratio of 0.02 for Q4 2023.
Telomir Pharmaceuticals (TELO) Debt Ratio (2023 - 2026) Analysis & Trends
Telomir Pharmaceuticals has reported Debt Ratio for 1 years, with the latest figure at 0.02 in Q4 2023.
- Quarterly Debt Ratio changed N/A year-over-year to 0.02 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.02 (changed N/A YoY) and the FY2023 annual result came in at 0.02, changed N/A from the prior year.
- Debt Ratio was little changed at 0.02 in Q4 2023 per TELO's latest filing.
- Over five years, Debt Ratio peaked at 0.02 in Q4 2023 and troughed at 0.02 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | Telomir Pharmaceuticals | 69.05 Mn | 69.05 Mn | - | 0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.03 |
| Dec 31, 2023 | 0.02 |